GR1001511B - Στεροειδείς συν?έσεις. - Google Patents

Στεροειδείς συν?έσεις.

Info

Publication number
GR1001511B
GR1001511B GR920100064A GR920100064A GR1001511B GR 1001511 B GR1001511 B GR 1001511B GR 920100064 A GR920100064 A GR 920100064A GR 920100064 A GR920100064 A GR 920100064A GR 1001511 B GR1001511 B GR 1001511B
Authority
GR
Greece
Prior art keywords
steroid formulations
role
steroid
formulations
tipredane
Prior art date
Application number
GR920100064A
Other languages
Greek (el)
English (en)
Inventor
Joy Elaine Dr Saunders
Original Assignee
Fisons Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ag filed Critical Fisons Ag
Publication of GR1001511B publication Critical patent/GR1001511B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
GR920100064A 1991-02-23 1992-02-18 Στεροειδείς συν?έσεις. GR1001511B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Publications (1)

Publication Number Publication Date
GR1001511B true GR1001511B (el) 1994-02-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100064A GR1001511B (el) 1991-02-23 1992-02-18 Στεροειδείς συν?έσεις.

Country Status (13)

Country Link
CN (1) CN1065010A (fr)
AU (1) AU1247192A (fr)
BE (1) BE1004177A4 (fr)
FR (1) FR2673104A1 (fr)
GB (1) GB9103824D0 (fr)
GR (1) GR1001511B (fr)
IE (1) IE920516A1 (fr)
IL (1) IL101010A0 (fr)
IT (1) IT1254627B (fr)
MX (1) MX9200748A (fr)
PT (1) PT100150A (fr)
WO (1) WO1992014473A1 (fr)
ZA (1) ZA921247B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (fr) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Gel thermoréversible utile comme excipient pharmaceutique pour une formation galénique
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
EP1645266A1 (fr) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Suspension aqueuse pour gouttes nasales
EP2057982A1 (fr) * 2007-11-09 2009-05-13 Archimedes Development Limited Compositions intranasales
WO2013049539A1 (fr) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. Procédé permettant de bloquer ou de piéger des allergènes
CN111787925A (zh) * 2017-10-11 2020-10-16 生命科学股份有限公司 N-乙酰神经氨酸组合物和使用方法
EP3923908A1 (fr) * 2019-02-11 2021-12-22 Reckitt Benckiser Health Limited Nouvelle composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (fr) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17 bis (thio substitué)-3-céto androstènes et compositions pharmaceutiques
EP0246652A2 (fr) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Formulations aqueuses de stéroides pour administration nasale
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (fr) * 1990-02-02 1991-08-08 Fisons Plc Compositions d'agents propulseurs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (fr) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17 bis (thio substitué)-3-céto androstènes et compositions pharmaceutiques
EP0246652A2 (fr) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Formulations aqueuses de stéroides pour administration nasale
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (fr) * 1990-02-02 1991-08-08 Fisons Plc Compositions d'agents propulseurs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
CN1065010A (zh) 1992-10-07
BE1004177A4 (fr) 1992-10-06
IL101010A0 (en) 1992-11-15
MX9200748A (es) 1992-10-01
FR2673104A1 (fr) 1992-08-28
AU1247192A (en) 1992-09-15
IE920516A1 (en) 1992-08-26
GB9103824D0 (en) 1991-04-10
ITMI920393A0 (it) 1992-02-21
PT100150A (pt) 1993-05-31
ITMI920393A1 (it) 1993-08-21
IT1254627B (it) 1995-09-28
WO1992014473A1 (fr) 1992-09-03
ZA921247B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
FI862011A0 (fi) Terapeutiska nukleosider.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
SE8804629D0 (sv) New therapeutically active compounds
SE7903186L (sv) Cerebralverksamt medel
ES2057604T3 (es) Enantiomero r de n-propargil-1-aminoindano, su preparacion y composiciones farmaceuticas que lo contienen.
NO970051L (no) Vandige risperidon formuleringer
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO163776C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner.
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR9709845B1 (pt) preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina.
NO865079L (no) Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.
GR1001511B (el) Στεροειδείς συν?έσεις.
AU7533091A (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
IT1240683B (it) Composizione farmaceutica contenente egf
ATE204752T1 (de) Therapeutische anwendungen von 2',5'- oligoadenylat-derivaten
DE59101404D1 (de) Topische Präparate.
ATE131725T1 (de) Formulierungen zur behandlung der vaginalen trockenheit
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.